Presentation is loading. Please wait.

Presentation is loading. Please wait.

Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled.

Similar presentations


Presentation on theme: "Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled."— Presentation transcript:

1 Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled trial  Bryan J M van de Wall, PhD, Marguerite A W Stam, PhD, Werner A Draaisma, PhD, R Stellato, PhD, Prof Willem A Bemelman, PhD, Prof Marja A Boermeester, PhD, Prof Ivo A M J Broeders, PhD, Eric J Belgers, PhD, Boudewijn R Toorenvliet, PhD, Hubert A Prins, PhD, Dr Esther C J Consten, PhD  The Lancet Gastroenterology & Hepatology  Volume 2, Issue 1, Pages (January 2017) DOI: /S (16) Copyright © 2017 Elsevier Ltd Terms and Conditions

2 Figure Trial profile *During analysis of the results we identified two patients who had been randomly assigned to receive elective resection, but had received a conservative treatment. The Lancet Gastroenterology & Hepatology 2017 2, 13-22DOI: ( /S (16) ) Copyright © 2017 Elsevier Ltd Terms and Conditions


Download ppt "Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled."

Similar presentations


Ads by Google